Literature DB >> 19027924

Generalized muscle pseudo-hypertrophy and stiffness associated with the myotilin Ser55Phe mutation: a novel myotilinopathy phenotype?

Josep Gamez1, Judith Armstrong, Alexey Shatunov, Albert Selva-O'Callaghan, Rosa Dominguez-Oronoz, Arantxa Ortega, Lev Goldfarb, Isidre Ferrer, Montse Olivé.   

Abstract

Myotilinopathies are a group of muscle disorders caused by mutations in the MYOT gene. It was first described in two families suffering from limb girdle muscle dystrophy type 1 (LGMD 1A), and later identified in a subset of dominant or sporadic patients suffering from myofibrillar myopathy, as well as in a family with spheroid body myopathy. Disease phenotypes associated with MYOT mutations are clinically heterogeneous and include pure LGMD forms as well as late-onset distal myopathies. We report here on a 53-year-old male suffering from a unique clinical profile characterized by generalized symmetrical increase in muscle bulk leading to a Herculean appearance. Muscle weakness and stiffness in the lower extremities were the patient's main complaints. Muscle MRI showed extensive fatty infiltration in the thigh and leg muscles and a muscle biopsy showed a myofibrillar myopathy with prominent protein aggregates. Gene sequencing revealed a Ser55Phe missense mutation in the myotilin gene. The mutation was identified in his older brother, who presented a mild hypertrophic appearance and had a myopathic pattern in EMG, despite not presenting any of the complaints of the proband and having normal muscle strength. This finding, and his deceased father and paternal aunt's similar gait disorders, suggest that this is in fact a new autosomal dominant kindred. The present observations further expand the spectrum of clinical manifestations associated with mutations in the myotilin gene.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19027924      PMCID: PMC2760960          DOI: 10.1016/j.jns.2008.10.019

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  19 in total

1.  Characterization of muscle filamin isoforms suggests a possible role of gamma-filamin/ABP-L in sarcomeric Z-disc formation.

Authors:  P F van der Ven; W M Obermann; B Lemke; M Gautel; K Weber; D O Fürst
Journal:  Cell Motil Cytoskeleton       Date:  2000-02

2.  Skeletal muscle pseudohypertrophy in primary amyloidosis.

Authors:  J N Whitaker; K Hashimoto; M Quinones
Journal:  Neurology       Date:  1977-01       Impact factor: 9.910

3.  Autosomal dominant "spheroid body myopathy".

Authors:  H H Goebel; J Muller; H W Gillen; A D Merritt
Journal:  Muscle Nerve       Date:  1978 Jan-Feb       Impact factor: 3.217

4.  Development of a microsatellite genetic map spanning 5q31-q33 and subsequent placement of the LGMD1A locus between D5S178 and IL9.

Authors:  L H Yamaoka; C A Westbrook; M C Speer; J M Gilchrist; E W Jabs; E G Schweins; J M Stajich; P C Gaskell; A D Roses; M A Pericak-Vance
Journal:  Neuromuscul Disord       Date:  1994 Sep-Nov       Impact factor: 4.296

5.  myotilin Mutation found in second pedigree with LGMD1A.

Authors:  Michael A Hauser; Cecilia B Conde; Valeria Kowaljow; Guillermo Zeppa; Ana L Taratuto; Udana M Torian; Jeffery Vance; Margaret A Pericak-Vance; Marcy C Speer; Alberto L Rosa
Journal:  Am J Hum Genet       Date:  2002-11-11       Impact factor: 11.025

6.  Mutations in myotilin cause myofibrillar myopathy.

Authors:  Duygu Selcen; Andrew G Engel
Journal:  Neurology       Date:  2004-04-27       Impact factor: 9.910

7.  Clinical and genetic investigation in autosomal dominant limb-girdle muscular dystrophy.

Authors:  J M Gilchrist; M Pericak-Vance; L Silverman; A D Roses
Journal:  Neurology       Date:  1988-01       Impact factor: 9.910

8.  Myotilin, the limb-girdle muscular dystrophy 1A (LGMD1A) protein, cross-links actin filaments and controls sarcomere assembly.

Authors:  Paula Salmikangas; Peter F M van der Ven; Maciej Lalowski; Anu Taivainen; Fang Zhao; Heli Suila; Rolf Schröder; Pekka Lappalainen; Dieter O Fürst; Olli Carpén
Journal:  Hum Mol Genet       Date:  2003-01-15       Impact factor: 6.150

9.  Autosomal-dominant distal myopathy with a myotilin S55F mutation: sorting out the phenotype.

Authors:  J Berciano; E Gallardo; R Domínguez-Perles; E Gallardo; A García; R García-Barredo; O Combarros; J Infante; I Illa
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-08-13       Impact factor: 10.154

10.  Hypothyroidism presenting as muscle stiffness and pseudohypertrophy: Hoffmann's syndrome.

Authors:  I Klein; M Parker; R Shebert; D R Ayyar; G S Levey
Journal:  Am J Med       Date:  1981-04       Impact factor: 4.965

View more
  5 in total

1.  Clinical and myopathological evaluation of early- and late-onset subtypes of myofibrillar myopathy.

Authors:  Montse Olivé; Zagaa Odgerel; Amaia Martínez; Juan José Poza; Federico García Bragado; Ramón J Zabalza; Ivonne Jericó; Laura Gonzalez-Mera; Alexey Shatunov; Hee Suk Lee; Judith Armstrong; Elías Maraví; Maria Ramos Arroyo; Jordi Pascual-Calvet; Carmen Navarro; Carmen Paradas; Mariano Huerta; Fabian Marquez; Eduardo Gutierrez- Rivas; Adolf Pou; Isidre Ferrer; Lev G Goldfarb
Journal:  Neuromuscul Disord       Date:  2011-06-14       Impact factor: 4.296

2.  Interplay between the ubiquitin-proteasome system and autophagy in proteinopathies.

Authors:  Qingwen Zheng; Jie Li; Xuejun Wang
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2009-05-08

3.  The actin associated protein palladin is important for the early smooth muscle cell differentiation.

Authors:  Li Jin; Qiong Gan; Bartosz J Zieba; Silvia M Goicoechea; Gary K Owens; Carol A Otey; Avril V Somlyo
Journal:  PLoS One       Date:  2010-09-22       Impact factor: 3.240

Review 4.  Myofibrillar Myopathies: New Perspectives from Animal Models to Potential Therapeutic Approaches.

Authors:  Sabrina Batonnet-Pichon; Anthony Behin; Eva Cabet; Florence Delort; Patrick Vicart; Alain Lilienbaum
Journal:  J Neuromuscul Dis       Date:  2017

5.  Unusual multisystemic involvement and a novel BAG3 mutation revealed by NGS screening in a large cohort of myofibrillar myopathies.

Authors:  Anna-Lena Semmler; Sabrina Sacconi; J Elisa Bach; Claus Liebe; Jan Bürmann; Rudolf A Kley; Andreas Ferbert; Roland Anderheiden; Peter Van den Bergh; Jean-Jacques Martin; Peter De Jonghe; Eva Neuen-Jacob; Oliver Müller; Marcus Deschauer; Markus Bergmann; J Michael Schröder; Matthias Vorgerd; Jörg B Schulz; Joachim Weis; Wolfram Kress; Kristl G Claeys
Journal:  Orphanet J Rare Dis       Date:  2014-08-01       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.